<!DOCTYPE html>
<html lang="zh-CN">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=5.0">
    <title>ç§‘ç ”æ—¥æŠ¥ - 2025-11-08</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, "Noto Sans", sans-serif, "Apple Color Emoji", "Segoe UI Emoji";
            line-height: 1.8;
            color: #2c3e50;
            background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
            padding: 15px;
            font-size: 16px;
        }

        .container {
            max-width: 900px;
            margin: 0 auto;
            background: white;
            padding: 35px;
            border-radius: 16px;
            box-shadow: 0 10px 40px rgba(0,0,0,0.1);
        }

        /* æ ‡é¢˜ä¼˜åŒ– */
        h1 {
            color: #1a202c;
            font-size: 2em;
            border-bottom: 4px solid #667eea;
            padding-bottom: 15px;
            margin-bottom: 25px;
            font-weight: 700;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
            background-clip: text;
        }

        h2 {
            color: #2d3748;
            font-size: 1.5em;
            margin-top: 40px;
            margin-bottom: 20px;
            padding-left: 15px;
            border-left: 5px solid #667eea;
            font-weight: 600;
        }

        h3 {
            color: #4a5568;
            font-size: 1.25em;
            margin-top: 28px;
            margin-bottom: 14px;
            font-weight: 600;
        }

        /* åˆ†ç±»æµè§ˆæŠ˜å åŠŸèƒ½ */
        details {
            margin: 20px 0;
            border-radius: 8px;
            overflow: hidden;
        }

        details summary {
            cursor: pointer;
            padding: 15px 20px;
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            color: #2d3748;
            font-size: 1.25em;
            font-weight: 600;
            text-align: right;
            direction: rtl;
            border-right: 5px solid #667eea;
            transition: all 0.3s ease;
            list-style: none;
            user-select: none;
        }

        details summary * {
            direction: ltr;
        }

        details summary::-webkit-details-marker {
            display: none;
        }

        details summary::before {
            content: 'â–¶';
            display: inline-block;
            margin-left: 10px;
            transition: transform 0.3s ease;
            font-size: 0.8em;
        }

        details[open] summary::before {
            transform: rotate(90deg);
        }

        details summary:hover {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            box-shadow: 0 4px 12px rgba(102, 126, 234, 0.3);
        }

        details[open] summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            border-right-color: white;
        }

        details .details-content {
            padding: 20px;
            background: white;
            border: 1px solid #e9ecef;
            border-top: none;
        }

        h4 {
            color: #718096;
            font-size: 1.1em;
            margin-top: 22px;
            margin-bottom: 12px;
            font-weight: 600;
        }

        p {
            margin-bottom: 16px;
            line-height: 1.8;
        }

        blockquote {
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            border-left: 4px solid #667eea;
            padding: 18px 22px;
            margin: 22px 0;
            border-radius: 8px;
            color: #4a5568;
            font-size: 0.95em;
            box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        }

        blockquote p {
            margin-bottom: 8px;
        }

        blockquote p:last-child {
            margin-bottom: 0;
        }

        blockquote em {
            font-style: normal;
            color: #718096;
            font-size: 0.9em;
        }

        blockquote a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        blockquote a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* é¡¶éƒ¨ç½²åï¼ˆå±…å³ï¼‰ */
        .powered-by-top {
            text-align: right;
            font-size: 0.85em;
            color: #718096;
            font-style: italic;
            margin: 12px 0;
            padding-right: 5px;
        }

        .powered-by-top a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        .powered-by-top a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* AI æ€»ç»“åŒºåŸŸä¼˜åŒ– */
        .ai-summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 28px;
            border-radius: 16px;
            margin: 30px 0;
            box-shadow: 0 12px 35px rgba(102, 126, 234, 0.35);
            position: relative;
            overflow: hidden;
        }

        .ai-summary::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -50%;
            width: 200%;
            height: 200%;
            background: radial-gradient(circle, rgba(255,255,255,0.1) 0%, transparent 70%);
            pointer-events: none;
        }

        .ai-summary h2 {
            color: white;
            border-left: none;
            border-right: none;
            margin-top: 0;
            margin-bottom: 18px;
            padding-left: 15px;
            padding-right: 0;
            text-align: left;
            direction: ltr;
        }

        .ai-summary h3 {
            color: #f0f0f0;
            margin-top: 18px;
            border-right: 3px solid rgba(255,255,255,0.5);
            padding-right: 12px;
            padding-left: 0;
            text-align: right;
            direction: rtl;
        }

        .ai-summary h3 * {
            direction: ltr;
        }

        .ai-summary blockquote {
            background: rgba(255,255,255,0.15);
            border-left-color: white;
            color: white;
            backdrop-filter: blur(10px);
        }

        .ai-summary p {
            color: white;
        }

        .ai-summary strong {
            color: #fff;
            font-weight: 600;
        }

        ul, ol {
            margin-left: 28px;
            margin-bottom: 18px;
        }

        li {
            margin-bottom: 12px;
            line-height: 1.8;
        }

        /* é“¾æ¥ä¼˜åŒ– */
        a {
            color: #667eea;
            text-decoration: none;
            border-bottom: 1px solid transparent;
            transition: all 0.3s ease;
            font-weight: 500;
        }

        a:hover {
            border-bottom-color: #667eea;
            color: #764ba2;
        }

        /* è¡¨æ ¼ä¼˜åŒ– */
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            box-shadow: 0 2px 12px rgba(0,0,0,0.08);
            border-radius: 10px;
            overflow: hidden;
        }

        th, td {
            border: 1px solid #e2e8f0;
            padding: 14px 18px;
            text-align: left;
        }

        th {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            font-weight: 600;
            font-size: 0.95em;
        }

        tr:nth-child(even) {
            background: #f8f9fa;
        }

        tr:hover {
            background: #e9ecef;
            transition: background 0.3s ease;
        }

        /* å…³é”®è¯ç»Ÿè®¡è¡¨æ ¼ç‰¹æ®Šæ ·å¼ï¼ˆæ›´ç´§å‡‘ï¼‰ */
        .keywords-table {
            font-size: 0.9em;
            max-width: 600px;
        }

        .keywords-table th,
        .keywords-table td {
            padding: 10px 14px;
        }

        .keywords-table th {
            font-size: 0.9em;
        }

        hr {
            border: none;
            border-top: 2px solid #e2e8f0;
            margin: 40px 0;
        }

        strong {
            color: #2d3748;
            font-weight: 600;
        }

        code {
            background: #f1f5f9;
            padding: 3px 8px;
            border-radius: 5px;
            font-family: "SF Mono", Monaco, Consolas, "Courier New", monospace;
            font-size: 0.9em;
            color: #e53e3e;
        }

        /* ç¾åŒ–æ»šåŠ¨æ¡ */
        ::-webkit-scrollbar {
            width: 8px;
            height: 8px;
        }

        ::-webkit-scrollbar-track {
            background: #f1f1f1;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb {
            background: #667eea;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb:hover {
            background: #764ba2;
        }

        /* ç§»åŠ¨ç«¯ä¼˜åŒ– */
        @media (max-width: 768px) {
            body {
                padding: 8px;
                font-size: 15px;
            }

            .container {
                padding: 22px 18px;
                border-radius: 12px;
            }

            h1 {
                font-size: 1.6em;
                padding-bottom: 12px;
                margin-bottom: 20px;
            }

            h2 {
                font-size: 1.3em;
                margin-top: 30px;
                padding-left: 12px;
            }

            h3 {
                font-size: 1.15em;
            }

            h4 {
                font-size: 1.05em;
            }

            blockquote {
                padding: 14px 16px;
                margin: 18px 0;
            }

            .ai-summary {
                padding: 20px;
                margin: 22px 0;
            }

            .ai-summary-header {
                flex-direction: column;
                align-items: flex-start;
            }

            .powered-by {
                margin-left: 0;
                margin-top: 8px;
            }

            table {
                font-size: 0.85em;
            }

            th, td {
                padding: 10px 12px;
            }

            .keywords-table {
                font-size: 0.8em;
            }

            .keywords-table th,
            .keywords-table td {
                padding: 8px 10px;
            }

            ul, ol {
                margin-left: 22px;
            }
        }

        /* è¶…å°å±å¹• */
        @media (max-width: 480px) {
            body {
                font-size: 14px;
                padding: 5px;
            }

            .container {
                padding: 18px 14px;
            }

            h1 {
                font-size: 1.4em;
            }

            h2 {
                font-size: 1.2em;
            }

            .ai-summary {
                padding: 16px;
            }

            .powered-by {
                font-size: 0.7em;
            }
        }

        /* å¹³æ»‘æ»šåŠ¨ */
        html {
            scroll-behavior: smooth;
        }

        /* æé«˜å¯ç‚¹å‡»åŒºåŸŸ */
        @media (pointer: coarse) {
            a {
                padding: 4px 0;
                display: inline-block;
            }
        }

        /* æ‰“å°ä¼˜åŒ– */
        @media print {
            body {
                background: white;
                padding: 0;
            }

            .container {
                box-shadow: none;
                max-width: 100%;
            }

            .ai-summary {
                background: #f5f5f5;
                color: black;
                box-shadow: none;
            }

            .ai-summary h2,
            .ai-summary h3,
            .ai-summary p,
            .ai-summary strong {
                color: black;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <h1>ğŸ“… Daily Report - 2025-11-08</h1>
<blockquote>
<p>ä»Šæ—¥ç­›é€‰å‡º <strong>93</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>5</strong> ä¸ªæ¥æº</p>
</blockquote>
<div class="powered-by-top">Powered by <a href="https://kyplus.de" target="_blank" rel="noopener noreferrer">ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href="https://claude.ai" target="_blank" rel="noopener noreferrer">Claude</a></div>

<hr />
<div class="ai-summary">
                <h2>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2>
                <h3>ğŸ“° å…¬ä¼—å·</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
çªç ´æ€§RNAæµ‹åºæŠ€æœ¯PRISMä¸€æ¬¡å¯æ£€æµ‹64ç§RNAï¼›å•ç»†èƒæ•°æ®æ¨æ–­ç»†èƒç‰¹å¼‚æ€§å› æœç½‘ç»œCSCNæ–°æ–¹æ³•ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- å•ç»†èƒåˆ†æè¯†åˆ«è‚¿ç˜¤å¾®ç¯å¢ƒä¸­çš„å…³é”®ç»†èƒäºšç¾¤ï¼ˆå¦‚HLA-DR+è‚¿ç˜¤ç»†èƒã€PLAUR+ä¸­æ€§ç²’ç»†èƒã€IL-33+å†…çš®ç»†èƒã€MMP11+æˆçº¤ç»´ç»†èƒï¼‰åŠå…¶å¯¹æ²»ç–—ï¼ˆå¦‚PD-1ã€CD8+Tç»†èƒï¼‰å’Œç–¾ç—…è¿›å±•çš„å½±å“ã€‚<br />
- æ•´åˆå¤šç»„å­¦ï¼ˆå•ç»†èƒã€ç©ºè½¬ã€é“ä»£è°¢ã€è‡ªå™¬ã€è¡°è€ã€çº¿ç²’ä½“åŠŸèƒ½ï¼‰åˆ†ææ­ç¤ºç–¾ç—…æœºåˆ¶åŠæ½œåœ¨é¶ç‚¹ã€‚<br />
- ç©ºé—´ç»„å­¦æŠ€æœ¯è”åˆåº”ç”¨ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- scranåŒ…ç®€åŒ–å•ç»†èƒRNA-seqæ•°æ®åˆ†ææµç¨‹ï¼›<br />
- CSCNæ¨¡å‹æ¨æ–­ç»†èƒç‰¹å¼‚æ€§å› æœç½‘ç»œï¼›<br />
- PRISMæŠ€æœ¯å®ç°é«˜é€šé‡RNAæ£€æµ‹ã€‚<br />
- metasensåŒ…ç”¨äºMetaåˆ†ææ•æ„Ÿæ€§åˆ†æã€‚</p>
<h3>ğŸ§¬ æ•°æ®å‰æ²¿</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
æ–°æ–¹æ³•PLAMseqå®ç°è›‹ç™½ç»„å­¦ä¸åŸºå› ç»„å­¦åŒæ­¥è¡¨å¾æŸ“è‰²è´¨ç›¸å…³è›‹ç™½åŠç›¸äº’ä½œç”¨ï¼›ç ”ç©¶æ­ç¤ºäº†æŸ“è‰²è´¨æŠ˜å ç¨‹åºé€šè¿‡æœ‰ä¸åˆ†è£‚æŸ“è‰²ä½“æˆ–ç»†èƒè´¨åœ¨ç»†èƒé—´ä¼ é€’ï¼Œé‡å¡‘äº’ä½œæ¨¡å¼ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
*   <strong>ç™Œç—‡è¡¨è§‚é—ä¼ å­¦è°ƒæ§</strong>ï¼šç ”ç©¶KDM5C, KDM6A, KMT2Båœ¨ç™Œç—‡è¡¨è§‚é—ä¼ å¤±è°ƒåŠè½¬å½•é‡ç¼–ç¨‹ä¸­çš„ä½œç”¨ï¼›é•¿é“¾éç¼–ç RNA UCA1è°ƒæ§SWI/SNFå¤åˆç‰©ä»‹å¯¼çš„æŸ“è‰²è´¨é‡å¡‘ã€‚<br />
*   <strong>æ¤ç‰©å“åº”ç¯å¢ƒèƒè¿«</strong>ï¼šæ¢ç´¢æ‹Ÿå—èŠ¥åœ¨å…‰ç…§å“åº”ä¸­æŸ“è‰²è´¨å¯åŠæ€§ä¸è½¬å½•åŠ¨æ€è°ƒæ§ï¼›è¥¿ç­ç‰™å†·æ‰å“åº”æ°”å€™èƒè¿«çš„è½¬å½•ç»„å­¦åˆ†æã€‚<br />
*   <strong>ä»£è°¢ä¸å…ç–«è°ƒæ§</strong>ï¼šChREBPè½¬å½•å› å­åœ¨èƒ½é‡ä»£è°¢ä¸­çš„æ–°å‹è°ƒæ§åŠŸèƒ½ï¼›è‚ é“èŒç¾¤äº§ç”Ÿçš„çŸ­é“¾è„‚è‚ªé…¸å¢å¼ºé»‘è‰²ç´ ç˜¤ç‰¹å¼‚æ€§Tç»†èƒå…ç–«ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
*   <strong>PLAMseq</strong>ï¼šä¸€ç§æ–°å‹å·¥ä½œæµç¨‹ï¼Œå¯åŒæ­¥è¿›è¡ŒæŸ“è‰²è´¨ç›¸å…³è›‹ç™½åŠè›‹ç™½ç›¸äº’ä½œç”¨çš„è›‹ç™½åŸºå› ç»„å­¦è¡¨å¾ã€‚<br />
*   <strong>å¤šç»„å­¦æ•´åˆ</strong>ï¼šç»“åˆ ATAC-seqã€RNA-seqã€WGBS ç­‰æŠ€æœ¯ï¼Œæ·±å…¥è§£æåŸºå› ç»„ã€è½¬å½•ç»„ã€è¡¨è§‚é—ä¼ ä¿®é¥°çš„ç›¸äº’ä½œç”¨ã€‚</p>
<h3>ğŸ”¬ æœŸåˆŠæ–‡ç« </h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
USP20é©±åŠ¨çš„èƒ†å›ºé†‡ä»£è°¢ä¸èƒ°è…ºç™Œç‚ç—‡ä¿¡å·ã€åŸºè´¨å…±åŒè¿›åŒ–ç´§å¯†å…³è”ï¼Œä¸ºé¶å‘æ²»ç–—æä¾›æ–°è§†è§’ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- é˜æ˜è‚¿ç˜¤ç›¸å…³å·¨å™¬ç»†èƒPGE2åœ¨ç»“ç›´è‚ ç™Œå…ç–«æ²»ç–—è€è¯ä¸­çš„ä½œç”¨æœºåˆ¶ã€‚<br />
- æ¢ç©¶å®ä½“ç˜¤ä¸­è‚¿ç˜¤ç»†èƒè¡¨å‹å¼‚è´¨æ€§å¯¹è‚¿ç˜¤å…ç–«å¾®ç¯å¢ƒç©ºé—´åŠ¨åŠ›å­¦çš„å½±å“ã€‚<br />
- åˆ†æè‚ºè…ºç™Œå‰ä½“ç—…å˜è¿›å±•ä¸­è‚ºæ³¡ç¥–ç»†èƒä¸ä¿ƒç‚ç”Ÿæ€ä½çš„ç©ºé—´å…±åŒè¿›åŒ–ã€‚<br />
- æ€»ç»“ç»†èƒè¡°è€åœ¨ç™Œå‰ç—…å˜ä¸­çš„åŒé‡ä½œç”¨åŠå…¶å¹²é¢„ç­–ç•¥ã€‚<br />
- å…³æ³¨ç™Œç—‡æ‚£è€…è‚¥èƒ–ã€è‚Œè‚‰è´¨é‡ä¸æ²»ç–—ååº”çš„å…³ç³»ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- æ•´åˆå¤šç»„å­¦æ•°æ®ï¼ˆä¸´åºŠé˜Ÿåˆ—ã€ç±»å™¨å®˜ã€æœ¬åœŸæ¨¡å‹ï¼‰æ­ç¤ºPDACè‚¿ç˜¤å†…æºæ€§ç‚ç—‡ä¸ä»£è°¢é‡ç¼–ç¨‹çš„ä¸²è”ã€‚<br />
- åˆ©ç”¨å¤šæ¨¡æ€ç©ºé—´ç»„å­¦ç²¾ç¡®è§£æè‚ºå‰ä½“ç—…å˜è¿›å±•ä¸­çš„ç»†èƒäº’ä½œå’Œç©ºé—´ç»“æ„ã€‚</p>
<h3>ğŸ“Š å­¦ç‚¹ç”Ÿä¿¡</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
"Computo"æœŸåˆŠçš„åˆ›åˆŠï¼Œæ ‡å¿—ç€ç»Ÿè®¡å­¦å’Œæœºå™¨å­¦ä¹ é¢†åŸŸå¯¹é€æ˜åŒ–å’Œå¯å¤ç°ç ”ç©¶çš„é‡è§†è¿ˆå…¥æ–°é˜¶æ®µã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- æ¨åŠ¨ç»Ÿè®¡å­¦ä¸æœºå™¨å­¦ä¹ æ–¹æ³•è®ºã€è®¡ç®—å’Œç®—æ³•çš„åˆ›æ–°ã€‚<br />
- ä¿ƒè¿›å¯¹æ¨¡å‹å’Œæ–¹æ³•é€‚ç”¨æ€§çš„æ·±å…¥ç†è§£ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- å¼ºè°ƒç ”ç©¶çš„é€æ˜åº¦å’Œå¯å¤ç°æ€§ã€‚<br />
- é¼“åŠ±å‘è¡¨æœ‰åŠ©äºç†è§£æ¨¡å‹ä¼˜åŠ£çš„è´¡çŒ®ã€‚</p>
<p><strong>å…¶ä»–ä¿¡æ¯</strong>ï¼š<br />
- 365 Data Science å°†äº2025å¹´11æœˆ6æ—¥è‡³21æ—¥æä¾›å¹³å°å…è´¹è®¿é—®ï¼ŒåŒ…å«Rç¼–ç¨‹ç­‰è¯¾ç¨‹ã€‚</p>
<h3>ğŸ§ª åšå®¢æ›´æ–°</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
SPT Labtech ä¸ Alithea Genomics åˆä½œï¼Œ<strong>é¦–æ¬¡</strong>å®ç°è¶…çµæ•å•ç»†èƒè½¬å½•ç»„å­¦æµç¨‹è‡ªåŠ¨åŒ–ï¼Œæ˜¾è‘—æå‡é€šé‡ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- ç»“åˆ RNA-seq å’Œå…¨åŸºå› ç»„è½¬å½•èµ·å§‹ä½ç‚¹é‰´å®šï¼Œå‘ç°æ–°å‹è°ƒæ§åŸºå› æ´»æ€§çš„æ ¸é…¶ï¼ˆriboswitchï¼‰ã€‚<br />
- å¼€å‘è®¡ç®—æ¨¡å‹ SegPoreï¼Œ<strong>çªç ´æ€§</strong>æå‡çº³ç±³å­”ç›´æ¥æµ‹åºä¸­ RNA ä¿®é¥°æ£€æµ‹çš„å‡†ç¡®æ€§ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- è‡ªåŠ¨åŒ–å•ç»†èƒ RNA æµ‹åºå·¥ä½œæµç¨‹ã€‚<br />
- åˆ©ç”¨ RNA-seq å’Œ dRNA-seq ç»˜åˆ¶è½¬å½•èµ·å§‹ä½ç‚¹ã€‚<br />
- åŸºäºçº³ç±³å­”ä¿¡å·çš„ RNA ä¿®é¥°æ£€æµ‹æ–°ç®—æ³•ã€‚</p>
            </div><h2>ğŸ“š åˆ†ç±»æµè§ˆ</h2>
<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ“° å…¬ä¼—å· (23æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>ä¸çœ‹ç»å¯¹åæ‚”ï¼scranåŒ…ï¼Œè½»æ¾æå®šå•ç»†èƒRNA-seqæ•°æ®åˆ†æï¼Œè®©ä½ å¿«é€ŸæŒæ¡ç»†èƒèšç±»ä¸åŸºå› ç­›é€‰ï¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šäº‘ç”Ÿä¿¡<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šRNA-seqã€RNAseqã€å•ç»†èƒã€scRNAã€RåŒ…ã€èšç±»<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg5MDk3Mzg4OA==&amp;mid=2247498448&amp;idx=1&amp;sn=1d6a10f348f45a7a98e944cf57aa0e2c" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>æœ€æ–°14+ç”Ÿä¿¡ï¼Œé€šè¿‡å•ç»†èƒåˆ†æè¯†åˆ«HLA-DR +è‚¿ç˜¤ç»†èƒï¼Œå¹¶åˆ†æå…¶å¯¹ CD8+T ç»†èƒåŠé¢„åçš„å½±å“ï¼Œæ€è·¯æ–°é¢–ï¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€å•ç»†èƒã€ç”Ÿä¿¡ã€é€šè·¯<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503883&amp;idx=7&amp;sn=10d6928d56958d0b79d647e8a238d152" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> â­ <strong>æœ€æ–°14+ç”Ÿä¿¡ï¼Œå•ç»†èƒè¯†åˆ«PLAUR+ä¸­æ€§ç²’ç»†èƒå¡‘é€ å…ç–«æŠ‘åˆ¶å¾®ç¯å¢ƒï¼ŒæŠ‘åˆ¶PLAUR å¢å¼ºæŠ— PD1 ç–—æ•ˆã€‚é«˜åˆ†æ–‡ç« ç»å…¸æ€è·¯ï¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«ã€å…ç–«å¾®ç¯å¢ƒã€å•ç»†èƒã€ç”Ÿä¿¡<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503883&amp;idx=5&amp;sn=ae227ecf3832d44e340d0d34c3bff717" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> â­ <strong>æœ€æ–°10+ç”Ÿä¿¡ï¼Œå•ç»†èƒ+ç©ºè½¬åˆ†æè‚Œé†‡ä»£è°¢åœ¨ç–¾ç—…ä¸­çš„ä½œç”¨ã€‚è¿™å·¥ä½œé‡è¿˜ä¸å¦‚å°ç¼–å¹³å¸¸åˆ†æçš„ä¸€åŠã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šä¸œæ™“ç”Ÿç‰©<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šä»£è°¢ã€å•ç»†èƒã€ç”Ÿä¿¡<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg2OTU2MzM2NA==&amp;mid=2247492988&amp;idx=1&amp;sn=e5c17176a90b04de541f6a35dc025cca" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> â­ <strong>å•ç»†èƒï¼‹é“ä»£è°¢ï¼ŒCellæ–°æ–‡è®²äº†ä¸€ä¸ªâ€œè‚¿ç˜¤åŠ«é“â€çš„æ•…äº‹</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°åšå£«<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€ä»£è°¢ã€å•ç»†èƒ<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šğŸ§  ä¸€ã€è‚¿ç˜¤éª¨è½¬ç§»å’Œè´«è¡€ï¼šä¸€ä¸ªä¸´åºŠè°œé¢˜åœ¨ä¸´åºŠä¸Šï¼Œéª¨è½¬ç§» + è´«è¡€ æ˜¯ç™Œç—‡æ™šæœŸæœ€æ£˜æ‰‹çš„ç»„åˆã€‚<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg2NDcxMzYwNg==&amp;mid=2247490340&amp;idx=1&amp;sn=ac1be3f6ad91bf7a53a2240d140bc190" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> â­ <strong>10.6åˆ†éè‚¿ç˜¤å¹²æ¹¿ç»“åˆç”Ÿä¿¡ï¼Œé¶å‘ CD177 + ä¸­æ€§ç²’ç»†èƒå‡è½»ç¼ºè¡€å†çŒæ³¨æŸä¼¤ã€‚é€‚åˆåŠ¨ç‰©å»ºæ¨¡æµ‹åºæ€è·¯ï¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€æµ‹åºã€ç”Ÿä¿¡<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503883&amp;idx=6&amp;sn=e57f0b0b9c89006329d32234142dd460" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> <strong>åˆšåˆšå‘è¡¨çš„8.9åˆ†ç”Ÿä¿¡ï¼Œé™¤äº†è¯†åˆ«æŸåŸºå› é˜³æ€§ç»†èƒï¼Œè¯†åˆ«æŸé€šè·¯/è¡¨å‹é˜³æ€§ç»†èƒä¹Ÿæ˜¯å‘æ–‡çš„å¥½æ€è·¯ï¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç”Ÿä¿¡ã€é€šè·¯<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503883&amp;idx=4&amp;sn=1939d01d6bda8e30c0aecc239cda850e" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> <strong>33+ç”Ÿä¿¡ï¼Œ è¯†åˆ«ä»ç™Œå‰ç—…å˜åˆ°è‚¿ç˜¤ä¸åŒæ¶æ€§ç¨‹åº¦ç›¸å…³çš„ç»†èƒäºšå‹ï¼Œé’ˆå¯¹IL-33+å†…çš®ç»†èƒä¿ƒè¿›ç–¾ç—…è¿›å±•è¿›è¡Œå®éªŒéªŒè¯ï¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€ç”Ÿä¿¡<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503883&amp;idx=3&amp;sn=b114d09c1ea514f69ae9c31d890850ca" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> <strong>æœ€æ–°7.5åˆ†ç”Ÿä¿¡ï¼Œä½œè€…æ•´åˆè‡ªå™¬+è¡°è€+ä¼‘çœ +çº¿ç²’ä½“åŠŸèƒ½+è‚¿ç˜¤å¹²æ€§è¿›è¡Œæ¨¡å‹æ„å»ºåŠéªŒè¯ã€‚è¿™ä¹ˆå¤šçƒ­ç‚¹ç»“åˆè¿˜æ˜¯ç¬¬ä¸€å›è§ï¼</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€ç”Ÿä¿¡<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503883&amp;idx=1&amp;sn=f929b54ddb5be29aa985d3f485b10fcd" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> <strong>ä½¿ç”¨Rè¯­è¨€è¿›è¡Œå®åŸºå› ç»„å­¦ç”Ÿä¿¡åˆ†æå…¨æµç¨‹ï½</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šä½œå›¾ä¸«<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šåŸºå› ç»„ã€ç”Ÿä¿¡<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šæœ€è¿‘æœ‰å°ä¼™ä¼´åæ˜ æ”¶ä¸åˆ°æ¨é€ï¼Œå› ä¸ºå…¬ä¼—å·æ”¹äº†æ¨é€ç®—æ³•ï¼Œç°åœ¨éœ€è¦åŠ æ˜Ÿæ ‡ï¼Œå¤šç‚¹èµã€ç‚¹åœ¨çœ‹ï¼Œæ‰èƒ½å‡†æ—¶æ”¶åˆ°æ¨é€å“¦ã€‚<br />
- ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg2NTE1MzU4NQ==&amp;mid=2247523374&amp;idx=1&amp;sn=88b756371cf7cdec4353683d40c78ecf" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<blockquote>
<p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 13 æ¡å†…å®¹ï¼Œè¯¦è§ <a href="#æ›´å¤š-å…¬ä¼—å·">æ–‡æœ«</a></p>
</blockquote>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§¬ æ•°æ®å‰æ²¿ (58æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>GSE295762 å¤šç»„å­¦é˜æ˜ KDM5Cã€KDM6A å’Œ KMT2B åœ¨ç™Œç—‡è¡¨è§‚é—ä¼ å¤±è°ƒå’Œè½¬å½•é‡ç¼–ç¨‹ä¸­çš„ä½œç”¨ [ATAC-seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€leukemiaã€immuneã€TMEã€metabolismã€metabolicã€metabolomeã€metabolomicsã€cardiacã€gliomaã€kinaseã€resistanceã€TCGAã€RNA-seqã€RNAseqã€DNA-seqã€ATAC-seqã€scRNAã€scDNAã€scATACã€spatialã€genomeã€genomicsã€transcriptomeã€transcriptomicsã€proteomeã€proteomicsã€Seuratã€Scanpyã€epigeneticã€epigenomeã€clustering<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributor : Tengjiao LiSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensHistone-modifying enzymes (HMEs) are critical regulators of tumorigenesis through epigenetic reprogramming. While mutations in HMEs are recognized drivers of cancer epigenome dysregulation, systematic comparative analyses of their mutational impacts and functional divergence across malignancies remain underexplored. This study addresses this gap by investigating three HMEsâ€”KDM5C (H3K4me3 demethylase), KMT2B (H3K4me3 methyltransferase), and KDM6A (H3K27me3 demethylase)â€”frequently mutated in diverse cancers. Using CRISPR/Cas9 knockout cell lines, we performed integrated multi-omics profiling encompassing genome-wide chromatin accessibility, transcriptomics, and chromatin-bound proteomics. Contrary to expectations that KMT2B loss (H3K4me3 depletion) and KDM5C loss (H3K4me3 accumulation) would induce opposing transcriptional programs, or that KDM6A deficiency (H3K27me3 accumulation) would exhibit distinct regulatory effects, our analyses revealed striking discrepancies between transcriptional outputs and chromatin-associated proteomic states across all three knockouts. Notably, each HME knockout elicited distinct transcriptional regulatory patterns, challenging conventional assumptions about their antagonistic or synergistic functions. These findings highlight context-dependent functional hierarchies among HMEs and underscore the necessity of multi-dimensional profiling to resolve epigenetic regulatory complexity. Our work advances the mechanistic understanding of cancer epigenetics and provides a framework for elucidating tumorigenic vulnerabilities linked to HME dysregulation.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295762" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>GSE295761 å¤šç»„å­¦é˜æ˜ KDM5Cã€KDM6A å’Œ KMT2B åœ¨ç™Œç—‡è¡¨è§‚é—ä¼ å¤±è°ƒå’Œè½¬å½•é‡ç¼–ç¨‹ä¸­çš„ä½œç”¨ [RNA-seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€leukemiaã€immuneã€TMEã€metabolismã€metabolicã€metabolomeã€cardiacã€gliomaã€kinaseã€resistanceã€TCGAã€RNA-seqã€RNAseqã€DNA-seqã€ATAC-seqã€scRNAã€scDNAã€scATACã€spatialã€genomeã€genomicsã€transcriptomeã€proteomeã€Seuratã€Scanpyã€epigeneticã€epigenomeã€clustering<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributor : Tengjiao LiSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensHistone-modifying enzymes (HMEs) are critical regulators of tumorigenesis through epigenetic reprogramming. While mutations in HMEs are recognized drivers of cancer epigenome dysregulation, systematic comparative analyses of their mutational impacts and functional divergence across malignancies remain underexplored. This study addresses this gap by investigating three HMEsâ€”KDM5C (H3K4me3 demethylase), KMT2B (H3K4me3 methyltransferase), and KDM6A (H3K27me3 demethylase)â€”frequently mutated in diverse cancers. Using CRISPR/Cas9 knockout cell lines, we performed integrated multi-omics profiling encompassing genome-wide chromatin accessibility, transcriptomics, and chromatin-bound proteomics. Contrary to expectations that KMT2B loss (H3K4me3 depletion) and KDM5C loss (H3K4me3 accumulation) would induce opposing transcriptional programs, or that KDM6A deficiency (H3K27me3 accumulation) would exhibit distinct regulatory effects, our analyses revealed striking discrepancies between transcriptional outputs and chromatin-associated proteomic states across all three knockouts. Notably, each HME knockout elicited distinct transcriptional regulatory patterns, challenging conventional assumptions about their antagonistic or synergistic functions. These findings highlight context-dependent functional hierarchies among HMEs and underscore the necessity of multi-dimensional profiling to resolve epigenetic regulatory complexity. Our work advances the mechanistic understanding of cancer epigenetics and provides a framework for elucidating tumorigenic vulnerabilities linked to HME dysregulation.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295761" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> â­ <strong>GSE306346 æŸ“è‰²è´¨è¿æ¥çš„ CPL2â€“PHD2/3 æ¨¡å—ç»´æŒå¤šç§ DNA ç”²åŸºåŒ–é€”å¾„å’Œ Polycomb æ²‰é»˜ [RNA-seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€immuneã€immunityã€TMEã€gliomaã€kinaseã€resistanceã€TCGAã€DepMapã€depmapã€RNA-seqã€RNAseqã€DNA-seqã€ChIP-seqã€ATAC-seqã€Hi-Cã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€genomeã€genomicsã€Scanpyã€methylationã€histoneã€pathway<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Lingrui Zhang ; Kai Tang ; Jian-Kang ZhuSeries Type : Expression profiling by high throughput sequencingOrganism : Arabidopsis thalianaWhile multiple chromatin-based epigenetic pathways are well characterized, their genome-wide coordination and hierarchical interplay remain poorly understood. We previously identified the BAHâ€“PHDâ€“CPL2 complex, where AIPP3 binds H3K27me3 via its BAH domain and, in concert with PHD2 and PHD3 (PHD2/3), recruits CPL2 to repress transcription by dephosphorylating RNA Polymerase II. Here, we show that CPL2 and PHD2/3 form a distinct module (CPL2â€“PHD2/3) that safeguards CHH DNA methylation and silences CHH-methylated sites at transposable elements (TEs) through engagement of multiple DNA methylation pathways. The CPL2â€“PHD2/3 module physically associates with SUVH4 and SUVH5 (SUVH4/5) to preserve SUVH4/5â€“CMT2-mediated CHH methylation at a subset of H3K9me2-marked regions. Chromatin enrichment of PHD3 likewise enables the module to sustain RNA-directed DNA methylation (RdDM)-mediated CHH DNA methylation at sites bearing H3K9me2, H3K27me3, or neither. Thus, CPL2â€“PHD2/3 emerges as a previously underappreciated, multifunctional regulator of plant DNA methylation networks. Unexpectedly, its gene repression function is uncoupled from DNA methylation. CPL2â€“PHD2/3 represses Polycomb-marked genes by interacting with LHP1 or recognizing hypomethylated H3K4. While it cooperates with LHP1 at a subset of targets, it also independently silences many more genes that LHP1 alone cannot repress, both sets of genes being critical for proper development. This dual, yet largely LHP1-insufficient, repression mode singles out CPL2â€“PHD2/3 as the essential executor of Polycomb silencing. Together, our findings establish CPL2â€“PHD2/3 as a chromatin-responsive integrator that spans DNA methylation and Polycomb-associated repression, providing a unifying mechanism for epigenetic control of both TEs and genes across diverse chromatin landscapes.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306346" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> â­ <strong>GSE288980 è¥¿ç­ç‰™å†·æ‰è½¬å½•ç»„åœ¨è‡ªç„¶ç¯å¢ƒä¸­çš„åŠ¨æ€å˜åŒ–ï¼šå‚ä¸æ°”å€™èƒè¿«å“åº”çš„ä»£è°¢é€”å¾„å’ŒåŸºå› ç½‘ç»œ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€TMEã€metabolismã€metabolicã€metabolomeã€gliomaã€kinaseã€TCGAã€DepMapã€depmapã€scRNAã€scDNAã€scATACã€spatialã€genomeã€genomicsã€transcriptomeã€transcriptomicsã€proteomeã€Seuratã€Scanpyã€epigeneticã€epigenomeã€histoneã€pathway<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Irene Blanca-Reyes ; MarÃ­a TorÃ©s-EspaÃ±a ; VÃ­ctor Lechuga ; MarÃ­a Teresa LlebrÃ©s ; Fernando N de la Torre ; JosÃ© A Carreira ; ConcepciÃ³n Ãvila ; Francisco M CÃ¡novas ; Vanessa Castro-RodriguezSeries Type : Expression profiling by high throughput sequencingOrganism : Abies pinsapoMediterranean forests such as those integrated by Spanish firs in southern Spain are extremely sensitive to the effects of climate climate-driven stresses. Recurrent periods of drought and prolonged warming in the last few years are major factors involves in the current vulnerability of local populations. In this work, physiological and transcriptional analyses were combined to assess the response of trees growing in the forest under natural conditions. The results show a modulation of the transcriptome in response to climatic stress with substantial changes in the expression of genes involved in water stress, aromatic amino acid metabolism, and transcription factors associated with the transcriptional regulation of the observed patterns of gene expression. Roots were determined to be the primary organs involved in the transcriptional response to stress which may be mediated by a gene-network including interactions among structural and regulatory genes. Interactive elements comprise genes encoding stress-related proteins of the ApLEA family, ApADH, the first committed enzyme in tyrosine biosynthesis, and root-specific transcription factors implicated in stress regulation belonging to the ApERF, ApYABBY and ApNAC superfamilies. Data provide new insights to understand the response of Spanish firs to current climatic disturbances by the identification of individual genes and gene-networks potentially involved in local adaptation. This new knowledge will facilitate comparative studies of gene variation in the Spanish fir populations using the identified genes as molecular markers for selection of the best adapted genotypes in the response of climate stress.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288980" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> â­ <strong>GSE282614 ä»£è°¢ç»„å­¦å’Œè½¬å½•ç»„å­¦åˆ†æçš„æ•´åˆæ­ç¤ºäº† ChREBP è½¬å½•å› å­åœ¨èƒ½é‡ä»£è°¢ä¸­çš„æ–°å‹è°ƒæ§åŠŸèƒ½</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€oncologyã€carcinomaã€immuneã€immunityã€TMEã€metabolismã€metabolicã€metabolomeã€metabolomicsã€gliomaã€resistanceã€TCGAã€scRNAã€scDNAã€scATACã€spatialã€genomeã€genomicsã€transcriptomeã€transcriptomicsã€proteomeã€Seuratã€Scanpyã€epigenomeã€clustering<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Jie An ; Inna Astapova ; Guofang Zhang ; Andrew L Cangelosi ; Olga Ilkayeva ; Hannah Marchuk ; Miachael J Muehlbauer ; Tabitha George ; Joseph Brozinick ; Mark A Herman ; Christopher B NewgardSeries Type : Expression profiling by high throughput sequencingOrganism : Rattus norvegicusCarbohydrate Response Element-Binding Protein (ChREBP) is a transcription factor that activates key genes involved in glucose, fructose, and lipid metabolism in response to carbohydrate feeding, but its other potential roles in metabolic homeostasis have not been as well studied. We used liver-selective GalNAc-siRNA technology to suppress expression of ChREBP in rats fed a high fat/high sucrose diet and characterized hepatic and systemic responses by integrating transcriptomic and metabolomic analyses. GalNAc-siChREBP-treated rats had lower levels of multiple short-chain acyl CoA metabolites compared to rats treated with GalNAc-siCtrl containing a non-targeting siRNA sequence. These changes were related to a sharp decrease in free CoA levels in GalNAc-siChREBP treated-rats, accompanied by lower expression of transcripts encoding enzymes and transporters involved in CoA biosynthesis. These activities of ChREBP likely contribute to its complex effects on hepatic lipid and energy metabolism. While core enzymes of fatty acid (FA) oxidation are induced by ChREBP knockdown, accumulation of liver acylcarnitines and circulating ketones indicate diversion of acetyl CoA to ketone production rather than complete oxidation in the TCA cycle. Despite strong suppression of pyruvate kinase and activation of pyruvate dehydrogenase, pyruvate levels were maintained, likely via increased expression of pyruvate transporters, and decreased expression of lactate dehydrogenase and alanine transaminase. GalNAc-siChREBP treatment increased hepatic citrate and isocitrate levels while decreasing levels of distal TCA cycle intermediates. The drop in free CoA levels, needed for the 2-ketoglutarate dehydrogenase reaction, as well as a decrease in transcripts encoding the anaplerotic enzymes pyruvate carboxylase, glutamate dehydrogenase, and aspartate transaminase likely contributed to these effects. GalNAc-siChREBP treatment caused striking increases in PRPP and ZMP/AICAR levels, and decreases in GMP, IMP, AMP, NaNM, NAD(P), and NAD(P)H levels, accompanied by reduced expression of enzymes that catalyze late steps in purine and NAD synthesis. ChREBP suppression also increased expression of a se...<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282614" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> â­ <strong>GSE281450 LHPPåœ¨ä¸‰é˜´æ€§ä¹³è…ºç™Œä¸­çš„è¡¨è¾¾é€šè¿‡è°ƒèŠ‚è‚¿ç˜¤å¾®ç¯å¢ƒä¿ƒè¿›è‚¿ç˜¤ç”Ÿé•¿å’Œè½¬ç§»</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€immuneã€tumor microenvironmentã€TMEã€metabolicã€metabolomeã€cardiacã€gliomaã€resistanceã€TCGAã€Hi-Cã€scRNAã€scATACã€10xã€spatialã€Visiumã€genomeã€proteomeã€Seuratã€Scanpyã€epigeneticã€epigenomeã€methylationã€histoneã€enrichment<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Jeffrey Reina ; Queralt Vallmajo-Martin ; Jia Ning ; Aubrey Michi ; Kay Yeung ; Geoffrey M Wahl ; Tony HunterSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensTriple-negative breast cancer (TNBC) is a highly aggressive and metastatic form of breast cancer that lacks an effective targeted therapy. To identify new therapeutic targets, we investigated the phosphohistidine phosphatase, LHPP, which has been implicated in the development of several types of cancer. However, the full significance of LHPP in cancer progression remains unclear due to our limited understanding of its molecular mechanism. We found that levels of the LHPP phosphohistidine phosphatase were significantly increased in human breast cancer patients compared to normal adjacent tissues, with the highest levels in the TNBC subtype. When LHPP was knocked out in the MDA-MB-231 human TNBC cell line, cell proliferation, wound healing capacity, and invasion were significantly reduced. However, LHPP knockout in TNBC cells did not affect the phosphohistidine protein levels. Interestingly, LHPP knockout in MDA-MB-231 cells delayed tumor growth and reduced metastasis when orthotopically transplanted into mouse mammary glands. To investigate LHPPâ€™s role in breast cancer progression, we used next-generation sequencing and proximity-labeling proteomics, and found that LHPP regulates gene expression in chemokine-mediated signaling and actin cytoskeleton organization. Depletion of LHPP reduced the presence of tumor-infiltrating macrophages in mouse xenografts. Our results uncover a new tumor promoter role for LHPP phosphohistidine phosphatase in TNBC and suggest that targeting LHPP phosphatase could be a potential therapeutic strategy for TNBC.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281450" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> â­ <strong>GSE302231 è‚ é“èŒç¾¤äº§ç”ŸçŸ­é“¾è„‚è‚ªé…¸çš„èƒ½åŠ›å¢å¼ºäº†é’ˆå¯¹é»‘è‰²ç´ ç˜¤çš„è‚¿ç˜¤ç‰¹å¼‚æ€§ CD127+CD8+ T ç»†èƒå…ç–«åŠ›</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€immuneã€immunityã€TMEã€cardiacã€gliomaã€TCGAã€Hi-Cã€single.cellã€single-cellã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€genomeã€genomicsã€proteomeã€proteomicsã€Seuratã€Scanpyã€epigeneticã€epigenome<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Annabell Bachem ; Michele Clarke ; Geraldine Kong ; Ilaryia Tarasova ; Lachlan Dryburgh ; Lindsay Kosack ; Ariane R Lee ; Lewis D Newland ; Teagan McGivern ; Emma Bawden ; Kah M Yap ; Michael Wilson ; Sven Engel ; Brendan E Russ ; Kshitij Tandon ; Grant McArthur ; Vanessa R Marcelino ; Paul A Beavis ; Stephen J Turner ; Jason Waithman ; Timothy P Stinear ; Shahneen Sandhu ; Jan Schroeder ; Thomas Gebhardt ; Sammy BedouiSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusGut microbiota modulate cancer control but how the different bacteria impact tumor-specific CD8+ T cell immunity remains unclear. Here, we identified that spontaneous control of cutaneous melanoma in mice correlated with microbiome-encoded metabolic pathways required for short-chain fatty acid (SCFA) synthesis. Diet-induced enforcement of microbial SCFA production reduced tumor progression and enriched tumor-specific CD8+ T cells in the tumor draining lymph node (tdLN) that lacked features of exhausted T cells. The SCFA butyrate promoted a FOXO1-dependent stemness program in these CD8+ T cells, enhanced the differentiation of CD127+CD8+ T cells and induced immune checkpoint blockade (ICB) responsiveness. Consistent with these experimental studies, metabolic modelling predicted enhanced microbial production of the SCFA butyrate in ICB-responsive melanoma patients and butyrate induced transcriptional features of ICB-responsiveness in CD8+ T cells. Collectively, these data identify the effects of microbial metabolic pathways on tumor-specific CD8+ T cell differentiation as critical components of how the gut microbiome regulates cancer immunity.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302231" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> â­ <strong>GSE283129 æ‹Ÿå—èŠ¥é®è«å“åº”åŸºå› è°ƒæ§ä¸­çš„è½¬å½•åŠ¨åŠ›å­¦å’ŒæŸ“è‰²è´¨å¯åŠæ€§ [ATAC-seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€immuneã€TMEã€cardiacã€gliomaã€TCGAã€RNA-seqã€RNAseqã€DNA-seqã€ChIP-seqã€ATAC-seqã€Hi-Cã€scRNAã€scDNAã€scATACã€spatialã€genomeã€genomicsã€transcriptomeã€transcriptomicsã€Seuratã€histoneã€enrichment<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Sandi PauliÅ¡iÄ‡ ; Alessandra Boccaccini ; Christian FankhauserSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Arabidopsis thalianaAccessible chromatin regions host DNA regulatory motives and are highly accessible to the transcription factors and transcriptional machinery. In Arabidopsis, responses to light are heavily regulated at the transcriptional level. Shade, for example, can limit photosynthesis and is rapidly perceived by phytochromes as a reduction of red to far-red light ratio. Under shade, phytochromes inactivate and allow PHYTOCHROME INTERACTING FACTORs (PIFs) to promote a wide scale genome reprogramming. A strong and fast initial regulation of shade responsive genes is followed by an attenuation of this response under prolonged shade. We wanted to determine if transcriptional response pattern to shade depends on chromatin accessibility. For this we used ATAC-seq to profile the chromatin of seedlings exposed to short (1h) and long (25h) simulated shade. Transcription pattern of most acute shade responsive genes correlates with the rapid increase in PIF levels/activity at 1h, and its decrease at 25h of shade exposure. For a set of acute responding genes, PIFs also modulate chromatin accessibility at their binding sites in response to shade. Our results suggest that permanent state of open chromatin conformation allows PIFs to easily access and recognize their binding motifs, rapidly initiating a burst in gene expression triggered by shade. This transcriptional response primarily depends on a transient increase in stability of PIFs and gene occupancy and is followed by a moderate change of chromatin accessibility.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283129" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> â­ <strong>GSE241408 FXRè¡¨è¾¾ä¸‹é™åè°ƒå°é¼ æ–°ç”Ÿå„¿Î²ç»†èƒæ•°é‡å‘è‚²ä¸å¾®ç”Ÿç‰©èƒ†æ±é…¸ä»£è°¢æˆç†Ÿ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€immuneã€TMEã€metabolismã€metabolicã€metabolomeã€cardiacã€gliomaã€resistanceã€DepMapã€depmapã€single.cellã€scRNAã€scDNAã€scATACã€10xã€spatialã€genomeã€genomicsã€proteomeã€proteomicsã€Seuratã€histone<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSeries Type : Genome binding/occupancy profiling by high throughput sequencing ; Expression profiling by high throughput sequencingOrganism : Mus musculusThis SuperSeries is composed of the SubSeries listed below.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE241408" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> â­ <strong>GSE309609 é—´æœŸæŸ“è‰²ä½“æ„è±¡ç”±é€šè¿‡æœ‰ä¸åˆ†è£‚æŸ“è‰²ä½“æˆ–ç»†èƒè´¨é—ä¼ çš„ä¸åŒæŠ˜å ç¨‹åºå†³å®š [SLAM-seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€oncologyã€TMEã€cardiacã€gliomaã€resistanceã€TCGAã€RNA-seqã€RNAseqã€DNA-seqã€ChIP-seqã€ATAC-seqã€scRNAã€scDNAã€scATACã€spatialã€genomeã€genomicsã€proteomeã€proteomicsã€Scanpyã€histone<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Athma Pai ; Job Dekker ; Allana Schooley ; Jesse W LehmanSeries Type : OtherOrganism : Homo sapiensIdentity-specific interphase chromosome conformation must be re-established each time a cell divides. To understand how interphase folding is inherited, we developed an experimental approach that segregates chromosome-intrinsic factors from those inherited through the cytoplasm during the establishment of G1 nuclear architecture. Endogenous RanGAP1 or Nup93 proteins were degraded in pro-metaphase arrested DLD-1 cells to prevent the establishment of nucleo-cytoplasmic transport during mitotic exit and isolate the decondensing mitotic chromatin of G1 daughter cells from the cytoplasm. Using this approach, we uncovered a transient folding intermediate entirely driven by chromosome-intrinsic factors. In addition to conventional compartmental segregation, this chromosome-intrinsic folding program leads to prominent genome-scale microcompartmentalization of mitotically bookmarked and cell type-specific cis-regulatory elements. The microcompartment conformation is formed during telophase and subsequently modulated by a second folding program driven by factors inherited through the cytoplasm in G1. The nuclear import-dependent folding program includes cohesin and factors involved in transcription and RNA processing. The combined and inter-dependent action of chromosome-intrinsic and cytoplasmic inherited folding programs determines the interphase chromatin conformation as cells exit mitosis.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309609" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<blockquote>
<p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 48 æ¡å†…å®¹ï¼Œè¯¦è§ <a href="#æ›´å¤š-æ•°æ®å‰æ²¿">æ–‡æœ«</a></p>
</blockquote>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ”¬ æœŸåˆŠæ–‡ç«  (7æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨7æ¡ï¼‰</h4>
<p><strong>1.</strong> <strong>USP20 é©±åŠ¨çš„èƒ†å›ºé†‡ä»£è°¢å°†ç‚ç—‡ä¿¡å·ä¼ å¯¼ä¸èƒ°è…ºç™Œçš„æ¶æ€§è‚¿ç˜¤å’ŒåŸºè´¨å…±åŒè¿›åŒ–è”ç³»èµ·æ¥</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€ä»£è°¢<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: ç‚ç—‡ä¿¡å·ä¼ å¯¼ã€ä»£è°¢é‡ç¼–ç¨‹å’ŒåŸºè´¨å¤æ‚æ€§å·²æˆä¸ºèƒ°è…ºå¯¼ç®¡è…ºç™Œ ï¼ˆPDACï¼‰ çš„æ ¸å¿ƒæ ‡å¿—ã€‚è¿™äº›ç¨‹åºä¹‹é—´çš„ä¸²æ‰°å¯èƒ½ä»£è¡¨åŒæ—¶æ‰°ä¹±å¤šä¸ªè‚¿ç˜¤ä¿ƒè¿›è¿‡ç¨‹çš„æ½œåœ¨é¶ç‚¹ã€‚é€šè¿‡æ•´åˆæ¥è‡ªä¸´åºŠé˜Ÿåˆ—ã€æ‚£è€…æ¥æºçš„ç±»å™¨å®˜å’Œæœ¬åœŸæ¨¡å‹çš„å¤šç»„å­¦æ•°æ®ï¼Œæˆ‘ä»¬å‘ç° PDAC ä¸­çš„è‚¿ç˜¤å†…æºæ€§ç‚ç—‡çº§è”ååº”æ˜¯ç”²ç¾ŸæˆŠé…¸é€”å¾„åŠ«æŒçš„ä¸»è¦è°ƒèŠ‚å› å­ï¼Œè¿™æ¨åŠ¨äº†æ¶æ€§è¿›å±•å’ŒåŸºè´¨å…±åŒè¿›åŒ–ã€‚TNFSF13B+ è‚¿ç˜¤ç›¸å…³å·¨å™¬ç»†èƒæ¿€æ´»è‚¿ç˜¤ä¸Šçš®ç»†èƒä¸­çš„ STAT3 ä¿¡å·ä¼ å¯¼ï¼Œå¯¼è‡´ USP20 çš„è½¬å½•ä¸Šè°ƒã€‚è¿™ç§å»æ³›ç´ é…¶ç¨³å®šäº† HMGCRï¼Œä»¥å¢å¼ºç”²ç¾ŸæˆŠé…¸é€šé‡ï¼Œå¯¼è‡´èƒ†å›ºé†‡å’Œé¦™å¶åŸºé¦™å¶é…°ç„¦ç£·é…¸ç›çš„äº§ç”Ÿè¿‡é‡ã€‚USP20 ä»‹å¯¼çš„ä»£è°¢æ”¹å˜è¯±å¯¼çš„ YAP/TAZ ä¿¡å·ä¼ å¯¼åˆºæ¿€ä¿ƒè¿›è‚¿ç˜¤ç»†èƒå¢æ®–å¹¶è§¦å‘ç™Œç—‡ç›¸å…³æˆçº¤ç»´ç»†èƒ ï¼ˆCAFï¼‰ çš„æ¿€æ´»ã€‚ä½¿ç”¨é€‰æ‹©æ€§æŠ‘åˆ¶å‰‚å¯¹ USP20 è¿›è¡ŒåŸºå› æ¶ˆèæˆ–è¯ç†å­¦æŠ‘åˆ¶å¯é€†è½¬è‚¿ç˜¤ä»£è°¢å¤±è°ƒï¼Œä»è€ŒæŠ‘åˆ¶è‚¿ç˜¤ç”Ÿé•¿å’ŒåŸºè´¨ç»“ç¼”å¢ç”Ÿã€‚æ­¤å¤–ï¼ŒUSP20 æŠ‘åˆ¶ä¸æŠ— PD-1/æŠ— CTLA-4<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1986639189233016832/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> <strong>è‚¿ç˜¤ç›¸å…³å·¨å™¬ç»†èƒäº§ç”Ÿ PGE2 ä»¥ä¿ƒè¿› CD8+ T ç»†èƒè€—ç«­å¹¶é©±åŠ¨å¾®å«æ˜Ÿç¨³å®šç»“ç›´è‚ ç™Œå¯¹ PD-L1 é˜»æ–­çš„è€è¯æ€§</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€è€è¯<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: å…ç–«æ£€æŸ¥ç‚¹é˜»æ–­æ²»ç–—å¯¹å¾®å«æ˜Ÿä¸ç¨³å®š ï¼ˆMSIï¼‰ ç»“ç›´è‚ ç™Œ ï¼ˆCRCï¼‰ éå¸¸æœ‰æ•ˆã€‚ç„¶è€Œï¼Œå¾®å«æ˜Ÿç¨³å®š ï¼ˆMSSï¼‰ è‚¿ç˜¤å¯¹å…ç–«æ²»ç–—å…·æœ‰å†…åœ¨çš„è€è¯æ€§ã€‚åœ¨è¿™é‡Œï¼Œæˆ‘ä»¬è¯•å›¾é€šè¿‡è¡¨å¾ MSS å’Œ MSI è‚¿ç˜¤æ¨¡å‹çš„å…ç–«è°±æ¥æ›´å¥½åœ°äº†è§£ CRC ä¸­æŠ— PD-L1 æ²»ç–—è€è¯çš„æœºåˆ¶ã€‚è™½ç„¶ä¸¤ç§è‚¿ç˜¤ç±»å‹éƒ½è¡¨ç°å‡ºç˜¤å†… CD8+ T ç»†èƒå’Œ PD-L1 è¡¨è¾¾ï¼Œä½†è€—å°½çš„ CD8+ T ç»†èƒè¡¨å‹ä¸åŒã€‚åœ¨ MSS è‚¿ç˜¤ä¸­ï¼Œè€—å°½çš„ CD8 + T ç»†èƒå…±è¡¨è¾¾ PD-1 å’Œ TIGITï¼Œå¹¶è¡¨ç°å‡ºç»ˆæœ«è€—å°½ç‰¹å¾ï¼Œç»†èƒå› å­åˆ†æ³Œä½ï¼Œç»†èƒæ¯’æ€§åŠŸèƒ½æœ‰é™ã€‚ç›¸æ¯”ä¹‹ä¸‹ï¼ŒMSI è‚¿ç˜¤ä¸­çš„ PD-1+ CD8+ T ç»†èƒä¸è¡¨è¾¾ TIGITï¼Œè¡¨ç°å‡ºæ›´é«˜çš„ç»†èƒå› å­å’Œç»†èƒæ¯’æ€§æ´»æ€§ã€‚æœ‰è¶£çš„æ˜¯ï¼Œå…ç–«æŠ‘åˆ¶æ€§ M2 æ ·è‚¿ç˜¤ç›¸å…³å·¨å™¬ç»†èƒï¼ˆTAMï¼‰åœ¨ MSI è‚¿ç˜¤ä¸­ç§¯ç´¯ï¼Œå¹¶ä¸ PD-1+ TIGIT+ CD8+ T ç»†èƒé¢‘ç‡å‘ˆæ­£ç›¸å…³ã€‚M2 æ · TAM è€—ç«­é™ä½äº† TIGIT<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1986639195407032320/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> <strong>è§£ç å®ä½“ç™Œä¸­è‚¿ç˜¤å’Œå…ç–«ç»†èƒç›¸äº’ä½œç”¨çš„ç©ºé—´åŠ¨åŠ›å­¦</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€å…ç–«<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: è‚¿ç˜¤å…ç–«å¾®ç¯å¢ƒ ï¼ˆTIMEï¼‰ çš„ç©ºé—´æ™¯è§‚ä½œä¸ºå®ä½“ç˜¤å…ç–«æ²»ç–—è€è¯çš„é©±åŠ¨å› ç´ æ­£åœ¨è¿›è¡Œé‡å¤§ç ”ç©¶ã€‚å¤§å¤šæ•°å·¥ä½œé›†ä¸­åœ¨è‚¿ç˜¤å†…ç”Ÿæ€ä½å†…çš„ç»„æˆå…ç–«ç»†èƒä¸Šï¼Œè€Œå¿½ç•¥äº†è‚¿ç˜¤ç»†èƒè¡¨å‹ã€‚ç„¶è€Œï¼Œç™Œç»†èƒé€šè¿‡å¤šç§æ–¹å¼å¡‘é€ å…¶ç¯å¢ƒï¼ŒåŒ…æ‹¬åˆ†æ³Œå’Œæ¶ˆè€—ä»£è°¢ç‰©ã€‚åœ¨è¿™é‡Œï¼Œæˆ‘ä»¬è®¤ä¸ºå°†ç™Œç»†èƒè¡¨å‹å¼‚è´¨æ€§æ•´åˆåˆ°ç©ºé—´åˆ†æä¸­å¯¹äºæ­ç¤ºäº§ç”Ÿ TIME å¤šæ ·æ€§çš„æœºåˆ¶å’Œæ›´å¥½åœ°è§£å†³å…ç–«æ²»ç–—çš„è€è¯æ€§è‡³å…³é‡è¦ã€‚<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1986593100974956544/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> <strong>å¤šæ¨¡æ€ç©ºé—´ç»„å­¦æ­ç¤ºäº†è‚ºå‰ä½“ç—…å˜è¿›å±•ä¸­è‚ºæ³¡ç¥–ç»†èƒå’Œä¿ƒç‚ç”Ÿæ€ä½çš„å…±åŒè¿›åŒ–</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç©ºé—´ç»„å­¦<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: ä¸åŒç»†èƒäºšç¾¤åœ¨è‚ºè…ºç™Œ ï¼ˆLUADï¼‰ å‰ä½“ç—…å˜è¿›å±•è¿‡ç¨‹ä¸­çš„å…±åŒè¿›åŒ–å°šä¸å®Œå…¨æ¸…æ¥šã€‚æˆ‘ä»¬ç”Ÿæˆäº†æ¥è‡ª 25 åæ‚£è€…çš„ 56 ä¸ªäººç±»å‰ä½“ç—…ç¶å’Œ LUAD çš„ç©ºé—´è½¬å½•ç»„å›¾è°±ï¼Œä»¥åŠæ¥è‡ª 19 åæ‚£è€…çš„ 36 ä¸ªç—…ç¶çš„ç‹¬ç«‹é˜Ÿåˆ—ï¼Œæ€»å…±åˆ†æäº† 486,519 ä¸ªæ–‘ç‚¹å’Œ 540 ä¸‡ä¸ªç»†èƒã€‚æˆ‘ä»¬ç¡®å®šäº†åŒºåˆ†å‰ä½“å’Œ LUAD çš„ç‰¹å®šåŒºåŸŸç¨‹åºã€‚ç©ºé—´åˆ†è¾¨çš„å…‹éš†ç»“æ„æ­ç¤ºäº† LUAD å‰ä½“è¿›åŒ–è¿‡ç¨‹ä¸­æ‚£è€…ç‰¹å¼‚æ€§çš„å¼‚è´¨æ€§ã€‚æˆ‘ä»¬å‘ç°è¡¨è¾¾è‚¿ç˜¤ç›¸å…³å…ƒç¨‹åºçš„ä¸Šçš®è‚ºæ³¡ç¥–ç»†èƒï¼Œå¹¶é©»ç•™åœ¨å¯Œå«ä¿ƒç‚äºšç¾¤ï¼ˆåŒ…æ‹¬ IL1B é«˜å·¨å™¬ç»†èƒï¼‰çš„ç”Ÿæ€ä½ä¸­ã€‚ä¸Šçš®ä¿ƒç‚ç”Ÿæ€ä½åœ¨å‰ä½“ç—…å˜ä¸­æ™®éå­˜åœ¨ï¼Œä½†åœ¨ LUAD ä¸­å˜å¾—ä¸é‚£ä¹ˆå¸¸è§ã€‚è¿™äº›ç”Ÿæ€ä½åœ¨å°é¼ ä¸­æ˜¯ä¿å®ˆçš„ï¼Œå¹¶ä¿ƒè¿›è‚ºæ³¡ç¥–ç»†èƒçš„ç”Ÿé•¿ã€‚åœ¨ç™Œå‰é˜¶æ®µå•ç‹¬é¶å‘ç‚ç—‡æˆ–ä¸å…ç–«æ£€æŸ¥ç‚¹é˜»æ–­è”åˆä½¿ç”¨å¯å‡å°‘è‚ºæ³¡ç¥–ç»†èƒã€‚ä¸Šçš®ç‚ç—‡ç”Ÿæ€ä½æ˜¯ç‰¹å®šé˜¶æ®µçš„ï¼Œå¡‘é€ äº†æ—©æœŸ LUAD çš„å‘å±•ï¼Œå¹¶ä»£è¡¨äº†æœ‰å¸Œæœ›çš„æ‹¦æˆªç›®æ ‡ã€‚<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1986593099565670400/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> <strong>ç™Œå‰ç—…å˜å’Œæ—©æœŸç™Œç—‡çš„ç»†èƒè¡°è€</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç™Œç—‡<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: ç»†èƒè¡°è€åœ¨ç™Œå‰ç—…å˜ä¸­èµ·ç€åŒé‡ä½œç”¨ï¼šæœ€åˆä½œä¸ºä¸Šçš®åŒºå®¤å†…çš„è‚¿ç˜¤æŠ‘åˆ¶å±éšœï¼Œåæ¥é€šè¿‡ç§°ä¸ºè¡°è€ç›¸å…³åˆ†æ³Œè¡¨å‹ ï¼ˆSASPï¼‰ çš„æŒç»­æ—åˆ†æ³Œç»„ä¿ƒè¿›ä¿ƒè‚¿ç˜¤ç™Œå‰ç»„ç»‡å¾®ç¯å¢ƒ ï¼ˆPreTMEï¼‰ã€‚æœ¬è¯„è®ºå¼ºè°ƒäº†è¡°è€åœ¨å„ç§ PreTME ç»†èƒç±»å‹ä¸­çš„ä½œç”¨ï¼Œæ¢ç´¢äº†æ–°å…´çš„è¯ç†å­¦å’Œç”Ÿæ´»æ–¹å¼æ‹¦æˆªç­–ç•¥ï¼Œå¹¶æ¦‚è¿°äº†æ¨è¿›ç”Ÿç‰©æ ‡å¿—ç‰©å’Œä¸´åºŠè½¬åŒ–çš„å½“å‰æŒ‘æˆ˜ã€‚<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1986593098714226688/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> <strong>è‚Œè‚‰è´¨é‡ã€è„†å¼±æ€§ã€å‡è‚¥å’Œç™Œç—‡æ²»ç–—</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç™Œç—‡<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: è¯¥è§‚ç‚¹è®¨è®ºäº†ä¸ç™Œç—‡å’Œè¶…é‡æˆ–è‚¥èƒ–æ‚£è€…è¯ç‰©æ²»ç–—ç›¸å…³çš„ä¸è‰¯ååº”ï¼Œå¹¶å¼ºè°ƒäº†ç”Ÿæ´»æ–¹å¼æ”¹å˜çš„é‡è¦æ€§ã€‚<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1986587539013279744/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> <strong>ç´¢é©¬é²è‚½å’Œæ›¿è¥¿å¸•è‚½æ²»ç–—æ—¢å¾€åˆå¹¶ç—‡ç™Œç—‡æ‚£è€…è‚¥èƒ–çš„å¤„æ–¹</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç™Œç—‡<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: è¿™é¡¹é˜Ÿåˆ—ç ”ç©¶æ¯”è¾ƒäº†æ‚£æœ‰è‡³å°‘ 1 ç§è‚¥èƒ–ç›¸å…³åˆå¹¶ç—‡å’Œæ–°è¯Šæ–­ç™Œç—‡çš„æˆå¹´äººä¸­èƒ°é«˜è¡€ç³–ç´ æ ·è‚½-1 å—ä½“æ¿€åŠ¨å‰‚çš„å‘ç—…ç‡å’Œæµè¡Œå¤„æ–¹ç‡ã€‚<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1986587582369800192/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ“Š å­¦ç‚¹ç”Ÿä¿¡ (2æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨2æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>Computoâ€”â€”ç»Ÿè®¡å­¦å’Œæœºå™¨å­¦ä¹ é¢†åŸŸé€æ˜ä¸”å¯å¤ç°ç ”ç©¶çš„æœŸåˆŠ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€TMEã€cardiacã€resistanceã€scRNAã€scDNAã€scATACã€spatialã€proteomeã€Seuratã€clustering<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šComputo is a journal promoting methodological, computational, and algorithmic contributions in statistics and machine learning that provide a better understanding of which models or methods are most appropriate to answer specific scientific questio... Continue reading: Computo â€“ A Journal for Transparent and Reproducible Research in Statistics and Machine Learning<br />
- ğŸ”— <a href="https://www.r-bloggers.com/2025/11/computo-a-journal-for-transparent-and-reproducible-research-in-statistics-and-machine-learning/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> <strong>365 Data Science æä¾›å…è´¹äººå·¥æ™ºèƒ½å’Œæ•°æ®è¯¾ç¨‹â€”â€”æ— é™æ¬¡è®¿é—®è‡³ 11 æœˆ 21 æ—¥</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šTME<br />
- ğŸ“ <strong>æè¿°</strong>ï¼š365 Data Science opens its doors this November 100% for free! From November 6 to November 21, 2025 (8 a.m. UTC), enjoy unlimited access to the entire platform, including a wide range of R programming courses and projects. This offer features expert-led courses, practical projects, and interactive exercises covering diverse topics in AI and data â€¦ ... Continue reading: Free AI and Data Courses with 365 Data Scienceâ€”Unlimited Access until Nov. 21<br />
- ğŸ”— <a href="https://www.r-bloggers.com/2025/11/free-ai-and-data-courses-with-365-data-science-unlimited-access-until-nov-21/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§ª åšå®¢æ›´æ–° (3æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨3æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>SPT Labtech å’Œ Alithea Genomics åˆä½œï¼Œå®ç°è¶…çµæ•å•ç»†èƒè½¬å½•ç»„å­¦å·¥ä½œæµç¨‹çš„è‡ªåŠ¨åŒ–</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€immuneã€TMEã€TCGAã€Hi-Cã€single.cellã€single-cellã€scRNAã€scDNAã€scATACã€spatialã€spatial transcriptomicsã€genomeã€genomicsã€transcriptomicsã€proteomicsã€Seuratã€histone<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSPT Labtech and Alithea Genomics have partnered to automate single-cell RNA sequencing, improving throughput...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/spt-labtech-and-alithea-genomics-collaborate-to-automate-ultra-sensitive-single-cell-transcriptomic-workflows/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>ç»“åˆRNAæµ‹åºå’Œå…¨åŸºå› ç»„è½¬å½•èµ·å§‹ä½ç‚¹é‰´å®šï¼Œå‘ç°æ ¸ç³–å¼€å…³</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šTMEã€TCGAã€RNA-seqã€RNAseqã€DNA-seqã€Hi-Cã€scRNAã€scDNAã€scATACã€genomeã€genomicsã€histone<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šResearchers used RNA sequencing and dRNA-seq to map transcription start sites and identify new riboswitches that regulate gene activity at the RNA level...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/riboswitch-discovery-by-combining-rna-seq-and-genome-wide-identification-of-transcriptional-start-sites/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> â­ <strong>ç ”ç©¶äººå‘˜æ¨å‡ºäº†ä¸€ç§æ–°å·¥å…·ï¼Œå¯ä»çº³ç±³å­”ä¿¡å·ä¸­æ›´å‡†ç¡®åœ°æ£€æµ‹RNAä¿®é¥°ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€TMEã€cardiacã€TCGAã€scRNAã€scDNAã€scATACã€Seurat<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šResearchers used RNA sequencing data to develop SegPore, a computational model that improves the accuracy of RNA modification detection from direct nanopore sequencing...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/researchers-introduce-a-new-tool-for-more-accurate-rna-modification-detection-from-nanopore-signals/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<h2>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2>
<table class="keywords-table">
<thead>
<tr>
<th>å…³é”®è¯</th>
<th>å‡ºç°æ¬¡æ•°</th>
</tr>
</thead>
<tbody>
<tr>
<td>scRNA</td>
<td>57</td>
</tr>
<tr>
<td>TME</td>
<td>56</td>
</tr>
<tr>
<td>genome</td>
<td>48</td>
</tr>
<tr>
<td>scDNA</td>
<td>46</td>
</tr>
<tr>
<td>Seurat</td>
<td>43</td>
</tr>
<tr>
<td>cancer</td>
<td>42</td>
</tr>
<tr>
<td>TCGA</td>
<td>42</td>
</tr>
<tr>
<td>scATAC</td>
<td>42</td>
</tr>
<tr>
<td>glioma</td>
<td>38</td>
</tr>
<tr>
<td>histone</td>
<td>33</td>
</tr>
<tr>
<td>spatial</td>
<td>32</td>
</tr>
<tr>
<td>genomics</td>
<td>31</td>
</tr>
<tr>
<td>cardiac</td>
<td>27</td>
</tr>
<tr>
<td>immune</td>
<td>26</td>
</tr>
<tr>
<td>proteome</td>
<td>25</td>
</tr>
<tr>
<td>tumor</td>
<td>24</td>
</tr>
<tr>
<td>resistance</td>
<td>22</td>
</tr>
<tr>
<td>RNAseq</td>
<td>19</td>
</tr>
<tr>
<td>Scanpy</td>
<td>19</td>
</tr>
<tr>
<td>RNA-seq</td>
<td>18</td>
</tr>
</tbody>
</table>
<hr />
<h2>ğŸ“ æ›´å¤šå†…å®¹</h2>
<details>
<summary><a name="æ›´å¤š-å…¬ä¼—å·"></a>ğŸ“° å…¬ä¼—å· å…¶ä»–å†…å®¹ (13æ¡)</summary>
<div class="details-content">
<ul>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzU3OTYwNjk1NA==&amp;mid=2247523307&amp;idx=1&amp;sn=997a9081b93e4348ec312903e6a7f7f6" target="_blank" rel="noopener noreferrer">å•ç»†èƒæµ‹åºæ”¶è´­å¤§æ¡ˆï¼šè´§æ¯”è´§å¾—æ‰”</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzU5MDcwNzg0MA==&amp;mid=2247657211&amp;idx=1&amp;sn=73be4b20aed661ec20308be64b2e4360" target="_blank" rel="noopener noreferrer">Cancer Cellï¼šç™Œå‰ç—…å˜å’Œæ—©æœŸç™Œç—‡ä¸­çš„ç»†èƒè¡°è€ | Cell Pressè®ºæ–‡é€Ÿé€’</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzYyNDMwNjg3Nw==&amp;mid=2247484014&amp;idx=1&amp;sn=3b259fd82984c9c576660b77e9b031e4" target="_blank" rel="noopener noreferrer">è¯¦è§£ï¼šå°¿æ¶²çš„ç”Ÿæˆå’Œä»£è°¢</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503883&amp;idx=8&amp;sn=a0400f7163306f6598f48ea7fb5ffdac" target="_blank" rel="noopener noreferrer">åˆšåˆšå‘è¡¨çš„14+ç”Ÿä¿¡åˆ†æï¼Œè¯†åˆ«MMP11+æˆçº¤ç»´ç»†èƒè¿›è¡Œåˆ†æå’ŒéªŒè¯ï¼Œæœ¬æ–‡æ€è·¯æ–°é¢–ï¼Œå€¼å¾—è®¤çœŸå­¦ä¹ æ¨¡ä»¿ï¼</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503883&amp;idx=2&amp;sn=d44c68299bb4d2008afd7b520fbc7e9c" target="_blank" rel="noopener noreferrer">ä»‹ç»ä¸¤ä¸ªç”Ÿä¿¡çƒ­ç‚¹å‘æ–‡æ€è·¯</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzkwMzY2NjkwNg==&amp;mid=2247495438&amp;idx=1&amp;sn=1cdd30fc65164515cf44c955b78ed70f" target="_blank" rel="noopener noreferrer">ä¸‰ç§ç©ºé—´ç»„å­¦æŠ€æœ¯çš„è”åˆåˆ†æï¼Œçœ‹çœ‹ä»–ä»¬æ˜¯æ€ä¹ˆç”¨çš„</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzkzNzY2NDgyOQ==&amp;mid=2247493114&amp;idx=1&amp;sn=3b218d27ab94cc1b7e54650fd9db0f9c" target="_blank" rel="noopener noreferrer">metasens åŒ…ç”¨äº metaåˆ†æä¸­çš„æ•æ„Ÿæ€§åˆ†æâ€“Copasé€‰æ‹©æ¨¡å‹</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzAxMDkxODM1Ng==&amp;mid=2247546777&amp;idx=1&amp;sn=fe878508b1ced474c88ad3d9ca093086" target="_blank" rel="noopener noreferrer">æœ€æ–°å•ç»†èƒmarkeræ•°æ®åº“å¤§ç›˜ç‚¹</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzkxMDY1MjU1OA==&amp;mid=2247488474&amp;idx=1&amp;sn=7bbb8e6af4632946d568cf93fe503513" target="_blank" rel="noopener noreferrer">æ–‡çŒ®åˆ† |Nature Biotechnologyï¼šçªç ´æ€§æŠ€æœ¯PRISMè¯ç”Ÿï¼šä¸€æ¬¡æ‹ç…§ï¼Œçœ‹æ¸…64ç§RNAï¼æ™®é€šæ˜¾å¾®é•œå°±èƒ½åš</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzkyNDI1MzE0NA==&amp;mid=2247490107&amp;idx=1&amp;sn=547f3c2cfe5d1a55f3ac359b583548a1" target="_blank" rel="noopener noreferrer">CSCNï¼šåŸºäºå•ç»†èƒæ•°æ®æ¨æ–­ç»†èƒç‰¹å¼‚æ€§å› æœç½‘ç»œ</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MjM5MzQ4NTk4MA==&amp;mid=2656509046&amp;idx=1&amp;sn=d5ca0ea6ec4d3b250570be6591d9a587" target="_blank" rel="noopener noreferrer">å¼ æ³½æ°‘é™¢å£«é¢†è¡”ï¼æ­ç¤ºå…¨ç¨‹æ–°è¾…åŠ©æ²»ç–—åœ¨å±€éƒ¨æ™šæœŸç›´è‚ ç™Œä¸­é‡å¡‘è‚¿ç˜¤å¾®ç¯å¢ƒçš„å…³é”®æœºåˆ¶</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzUxMzk5MjY5NA==&amp;mid=2247649545&amp;idx=1&amp;sn=466e5a7142298f891b9102a88ef21ceb" target="_blank" rel="noopener noreferrer">é‡åº†åŒ»ç§‘å¤§å­¦å¼ æ³½æ°‘é™¢å£«å›¢é˜Ÿè¿å‘ä¸¤ç¯‡ Cancer Cellï¼</a></li>
<li><a href="https://mp.weixin.qq.com/s?__biz=MzkxODY4NDEwMA==&amp;mid=2247489644&amp;idx=1&amp;sn=f8e78494b8618739d484d8ac1fc06f36" target="_blank" rel="noopener noreferrer">ç¥ç»å…ç–«ç‚ç—‡çš„çº¿ç²’ä½“è°ƒæ§</a></li>
</ul>
</div>
</details>

<details>
<summary><a name="æ›´å¤š-æ•°æ®å‰æ²¿"></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (48æ¡)</summary>
<div class="details-content">
<ul>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE277731" target="_blank" rel="noopener noreferrer">GSE277731 é—´æœŸæŸ“è‰²ä½“æ„è±¡ç”±é€šè¿‡æœ‰ä¸åˆ†è£‚æŸ“è‰²ä½“æˆ–ç»†èƒè´¨é—ä¼ çš„ä¸åŒæŠ˜å ç¨‹åºå†³å®š [ATAC-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294161" target="_blank" rel="noopener noreferrer">GSE294161 PLAMseq èƒ½å¤Ÿåœ¨å•ä¸ªå·¥ä½œæµç¨‹ä¸­åŒæ—¶å¯¹æŸ“è‰²è´¨ç›¸å…³è›‹ç™½å’Œè›‹ç™½è´¨ç›¸äº’ä½œç”¨è¿›è¡Œè›‹ç™½è´¨åŸºå› ç»„å­¦è¡¨å¾ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE286325" target="_blank" rel="noopener noreferrer">GSE286325ï¼šCOVID-19 åæ‚£è€…ç»å…¸å•æ ¸ç»†èƒçš„è½¬å½•ç»„æç¤ºå­˜åœ¨æ˜“æ„Ÿå› ç´ æˆ– SARS-CoV-2 æ„ŸæŸ“çš„å…ˆå¤©è®°å¿†</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283133" target="_blank" rel="noopener noreferrer">GSE283133 æ‹Ÿå—èŠ¥ä¸­é®è«å“åº”åŸºå› è°ƒæ§çš„è½¬å½•åŠ¨åŠ›å­¦å’ŒæŸ“è‰²è´¨å¯åŠæ€§ [RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE280932" target="_blank" rel="noopener noreferrer">GSE280932 é•¿é“¾éç¼–ç RNA UCA1é€šè¿‡å«SMARCA2çš„SWI/SNFå¤åˆç‰©è°ƒæ§äººç±»ç»“ç›´è‚ ç™Œä¸­çš„æŸ“è‰²è´¨é‡å¡‘</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306349" target="_blank" rel="noopener noreferrer">GSE306349 æŸ“è‰²è´¨è¿æ¥çš„ CPL2â€“PHD2/3 æ¨¡å—ç»´æŒå¤šç§ DNA ç”²åŸºåŒ–é€”å¾„å’Œ Polycomb æ²‰é»˜ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306347" target="_blank" rel="noopener noreferrer">GSE306347 æŸ“è‰²è´¨è¿æ¥çš„ CPL2â€“PHD2/3 æ¨¡å—ç»´æŒå¤šç§ DNA ç”²åŸºåŒ–é€”å¾„å’Œ Polycomb æ²‰é»˜ [WGBS]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300167" target="_blank" rel="noopener noreferrer">GSE300167 æŠ‘åˆ¶ç™½ç»†èƒä»‹ç´ -1 å—ä½“ç›¸å…³æ¿€é…¶ (IRAK)-4 å¯éƒ¨åˆ†æŒ½æ•‘ç™½ç»†èƒä»‹ç´ -1 Î² è¯±å¯¼çš„é©¬è‚Œè…±ç»†èƒåŠŸèƒ½å’ŒåŸºå› è¡¨è¾¾å˜åŒ–ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE277875" target="_blank" rel="noopener noreferrer">GSE277875 é—´æœŸæŸ“è‰²ä½“æ„è±¡ç”±é€šè¿‡æœ‰ä¸åˆ†è£‚æŸ“è‰²ä½“æˆ–ç»†èƒè´¨é—ä¼ çš„ä¸åŒæŠ˜å ç¨‹åºæŒ‡å®š [Hi-C]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285294" target="_blank" rel="noopener noreferrer">GSE285294 å¤§éº»ä½¿ç”¨å’Œå¤§éº»äºŒé…šè°ƒèŠ‚HIVè¯±å¯¼çš„TREM2è¡¨è¾¾æ”¹å˜ï¼šå¯¹å¹´é¾„ç›¸å…³ç¥ç»ç—…ç†å‘ç”Ÿçš„å½±å“</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE269164" target="_blank" rel="noopener noreferrer">GSE269164 å•ç»†èƒåˆ†ææ­ç¤ºäº†å¿ƒè„å†ç”Ÿè¿‡ç¨‹ä¸­éå¿ƒè‚Œç»†èƒçš„è¡¨è§‚é—ä¼ é‡å¡‘å’Œå…³é”®æ•ˆåº”å› å­ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE284662" target="_blank" rel="noopener noreferrer">GSE284662 éšçƒèŒåˆ©ç”¨å»¶è¿Ÿçš„å°èƒ¶è´¨ç»†èƒæ´»åŒ–ï¼Œè€Œå°èƒ¶è´¨ç»†èƒéª¨æ¡¥è›‹ç™½ï¼ˆOPN/Spp1ï¼‰ä¼šæŸå®³å¤–å‘¨å®¿ä¸»çš„æ§åˆ¶èƒ½åŠ›</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308844" target="_blank" rel="noopener noreferrer">GSE308844 é—´æœŸæŸ“è‰²ä½“æ„è±¡ç”±é€šè¿‡æœ‰ä¸åˆ†è£‚æŸ“è‰²ä½“æˆ–ç»†èƒè´¨é—ä¼ çš„ä¸åŒæŠ˜å ç¨‹åºæŒ‡å®š [CUT&amp;Run]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299670" target="_blank" rel="noopener noreferrer">GSE299670 ç”µåŠ¿å¯¹åç¡åŒ–æ¡ä»¶ä¸‹å‰¯çƒèŒè½¬å½•ç»„çš„å½±å“</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298902" target="_blank" rel="noopener noreferrer">GSE298902 å†…çš®ç»†èƒé€šè¿‡æŸ“è‰²è´¨é‡å¡‘ä¿ç•™ç‚ç—‡è®°å¿† [ATAC-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE278023" target="_blank" rel="noopener noreferrer">GSE278023 é—´æœŸæŸ“è‰²ä½“æ„è±¡ç”±ä¸åŒçš„æŠ˜å ç¨‹åºå†³å®šï¼Œè¿™äº›ç¨‹åºé€šè¿‡æœ‰ä¸åˆ†è£‚æŸ“è‰²ä½“æˆ–ç»†èƒè´¨é—ä¼ ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE280802" target="_blank" rel="noopener noreferrer">GSE280802 äººç±»ç»†èƒä¸­iNOSä»‹å¯¼çš„å†…æºæ€§ä¸€æ°§åŒ–æ°®ç”Ÿæˆé™åˆ¶ç‚ç—‡æ¿€æ´»å’Œèƒ†å›ºé†‡/è„‚è‚ªé…¸ç”Ÿç‰©åˆæˆ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299114" target="_blank" rel="noopener noreferrer">GSE299114 å†…çš®ç»†èƒé€šè¿‡æŸ“è‰²è´¨é‡å¡‘ä¿ç•™ç‚ç—‡è®°å¿† [RNA-Seq 2]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291524" target="_blank" rel="noopener noreferrer">GSE291524 ColoStemï¼Œä¸€ç§è¯†åˆ«é¢„åä¸è‰¯çš„èƒå„¿å‹ç»“ç›´è‚ è‚¿ç˜¤çš„æ ¸å¿ƒè½¬å½•ç‰¹å¾</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300949" target="_blank" rel="noopener noreferrer">GSE300949 å°é¼ è„‘è†œæ˜¯ä¸€ä¸ªå…·æœ‰éŸ§æ€§çš„ B ç»†èƒæ·‹å·´ç”Ÿæˆåº“ï¼Œå¯æä¾›å¯¹æ„ŸæŸ“çš„ä¿æŠ¤ [BCR-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302718" target="_blank" rel="noopener noreferrer">GSE302718 é«˜åº¦åŠŸèƒ½æ€§çš„æŒç»­æ€§GC-TFHååº”ä¸å¢å¼ºçš„ä¸­å’ŒæŠ—ä½“ç”Ÿæˆç›¸å…³</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271647" target="_blank" rel="noopener noreferrer">GSE271647 æå±æ¨±æ¡ƒÃ—åˆºæ¨±æ¡ƒâ€˜äº”æ®¿åœºæ¨±â€™çš„æ°”ç”Ÿæ ¹ç”Ÿé•¿æœºåˆ¶åŠå…¶è€æ¶æ€§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283052" target="_blank" rel="noopener noreferrer">GSE283052 12ä¾‹ç»“ç›´è‚ ç™Œè‚¿ç˜¤ç»„ç»‡çš„ç©ºé—´è½¬å½•ç»„å­¦åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE275423" target="_blank" rel="noopener noreferrer">GSE275423 MTHFD2ä»‹å¯¼çš„FOXO1æ³›ç´ åŒ–å’Œé™è§£ä¿ƒè¿›èˆŒé³çŠ¶ç»†èƒç™Œè¿›å±•</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308880" target="_blank" rel="noopener noreferrer">GSE308880 é…’ç²¾ä¾èµ–è¯±å¯¼ä¼éš”æ ¸æ˜Ÿå½¢èƒ¶è´¨ç»†èƒå…ç–«æ¿€æ´»</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE301784" target="_blank" rel="noopener noreferrer">GSE301784 å†…çš®ç»†èƒé€šè¿‡æŸ“è‰²è´¨é‡å¡‘ä¿ç•™ç‚ç—‡è®°å¿† [ATAC]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303078" target="_blank" rel="noopener noreferrer">GSE303078 çªè§¦è›‹ç™½åœ¨è¡°è€è¿‡ç¨‹ä¸­èšé›†å’Œé™è§£é€Ÿåº¦å‡æ…¢ï¼Œå¹¶åœ¨å°èƒ¶è´¨ç»†èƒä¸­ç§¯ç´¯ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299075" target="_blank" rel="noopener noreferrer">GSE299075 CTNNB1 çªå˜å¯¹èƒšèƒå¹²ç»†èƒä¿¡å·ä¼ å¯¼å…·æœ‰å¤šç§å½±å“</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297594" target="_blank" rel="noopener noreferrer">GSE297594 MeCP2 è°ƒæ§äººç±»è„‘ç±»å™¨å®˜ç«¯è„‘å‘è‚²</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300640" target="_blank" rel="noopener noreferrer">GSE300640 è§†äº¤å‰ä¸Šæ ¸é€šè¿‡ADRB3-S100Bè½´è°ƒæ§æ£•è‰²è„‚è‚ªäº§çƒ­</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287392" target="_blank" rel="noopener noreferrer">GSE287392 PDE4B ç¼ºé™·æœ‰åŠ©äºå·¨å™¬ç»†èƒç‰¹æ´›ä¼Šæœ¨é©¬å°†æ–°å‹éšçƒèŒè½¬ç§»åˆ°å¤§è„‘ä¸­</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281226" target="_blank" rel="noopener noreferrer">GSE281226 å†…è’™å¤ç»’å±±ç¾Šèƒå„¿ï¼ˆ55æ—¥é¾„ï¼‰çš®è‚¤ä¸Šçš®ç»†èƒæ¥æºçš„å¤–æ³Œä½“çš„å°RNAæµ‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE270486" target="_blank" rel="noopener noreferrer">GSE270486 è„Šæ¤åŠ¨ç‰©è„‘è¾¹ç•Œæ¸…é“å¤«ç»†èƒå‘è‚²çš„è¶‹åŒè¿›åŒ–</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299261" target="_blank" rel="noopener noreferrer">GSE299261 å†…çš®ç»†èƒé€šè¿‡æŸ“è‰²è´¨é‡å¡‘ä¿ç•™ç‚ç—‡è®°å¿† II</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298859" target="_blank" rel="noopener noreferrer">GSE298859 å†…çš®ç»†èƒé€šè¿‡æŸ“è‰²è´¨é‡å¡‘ä¿ç•™ç‚ç—‡è®°å¿†</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272310" target="_blank" rel="noopener noreferrer">GSE272310 DRBD3 è°ƒæ§é”¥è™«ä¸­é•¿é“¾éç¼–ç  RNA çš„ä¸°åº¦å’Œéšè”½å‰ªæ¥ä½ç‚¹çš„é€‰æ‹©</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297581" target="_blank" rel="noopener noreferrer">GSE297581 å°é¼ è„‘è†œæ˜¯ä¸€ä¸ªå…·æœ‰å¼ºå¤§æŠµæŠ—åŠ›çš„Bç»†èƒæ·‹å·´ç”Ÿæˆåº“ï¼Œèƒ½å¤Ÿæä¾›é’ˆå¯¹æ„ŸæŸ“çš„ä¿æŠ¤ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289443" target="_blank" rel="noopener noreferrer">GSE289443 çŠ¬ç”²çŠ¶è…ºç™Œçš„ RNA-seq åˆ†æã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303126" target="_blank" rel="noopener noreferrer">GSE303126 æŠ‘åˆ¶è¡€çº¢ç´ ç”Ÿç‰©åˆæˆå¯è¯±å¯¼æ€¥æ€§é«“ç³»ç™½è¡€ç—…ç»†èƒå‘ç”Ÿé“œå‡‹äº¡</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302799" target="_blank" rel="noopener noreferrer">GSE302799 é€šè¿‡é¶å‘æ€§æŸ“è‰²ä½“ä¼ é€’æ‰­æ›²äº§ç”Ÿçš„é›Œæ€§æˆ–é›„æ€§åå‘åä»£</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE268983" target="_blank" rel="noopener noreferrer">GSE268983 HIVç›¸å…³å¿ƒè„åŠŸèƒ½éšœç¢çš„åˆ†å­æœºåˆ¶</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE275482" target="_blank" rel="noopener noreferrer">GSE275482 å°é¼ å‰åˆ—è…ºäºŒç»´å’Œä¸‰ç»´ç±»å™¨å®˜çš„å•ç»†èƒRNAæµ‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292767" target="_blank" rel="noopener noreferrer">GSE292767 MCF7 å’Œ MDA-MB-231 RNA-seq</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272642" target="_blank" rel="noopener noreferrer">GSE272642 äººç±»å¤§è„‘å‘è‚²æ‰€éœ€çš„è½¬åº§é…¶è¡ç”ŸåŸºå› </a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281346" target="_blank" rel="noopener noreferrer">GSE281346 IL-17A é€šè¿‡è°ƒèŠ‚ä¿ƒçº¢ç»†èƒç”Ÿæˆç´ åé¦ˆå›è·¯æ¥åˆºæ¿€çº¢ç»†èƒç”Ÿæˆã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281321" target="_blank" rel="noopener noreferrer">GSE281321 å°¼æ´›æ›¿å°¼æ²»ç–—äº¨å»·é¡¿ç—…æ‚£è€…çš„è‡ªå™¬å’Œç¥ç»èƒ¶è´¨ç»†èƒæ´»æ€§æ”¹å˜</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292849" target="_blank" rel="noopener noreferrer">GSE292849 AT3 RNA-seq</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292768" target="_blank" rel="noopener noreferrer">GSE292768 MCF7 ChIP-seq</a></li>
</ul>
</div>
</details>

<hr />
<p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2025-11-07 21:37</em><br />
<em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p>
    </div>
</body>
</html>